Pediatrics Journal Club Guide
Goals of Journal Club
Expectations for Journal Club
Participants
Presenters
Structure
8:00 - 8:10 | Each pair of presenters presents the brief background and research question being addressed by their paper |
8:10 - 8:20 | Breakout groups use the template to compose a causal hypothesis. Goal is to develop a study to answer the research question |
8:20 - 8:30 | Each group presents their study design and answers (~2 min per group) |
8:30 - 9:00 | Leaders discuss structure of the study. Discussion of differences, strengths, weaknesses, and clinical application |
Causal Hypothesis
Content adapted from CTS601A, Dr. William Jesdale
Vocabulary
Exposure → Outcome, in Context
Components of a Causal Hypothesis
Exposure → Outcome, in Context
Conceptual definition: What is the idea? (intention)
Operational realization: How does a given person get assigned an exposure status? An outcome status? Included in study population? (actual)
Content adapted from CTS601A, Dr. William Jesdale
Study Design (Type of study) | |
Exposure (Independent variable - the “cause” of what you are studying) | Conceptually: Operationally: |
Exposure Contrast (Reference group - compared to what alternative) | Conceptually: Operationally: |
Etiologic Period (Time period of reference) | |
Causal Direction (Effect) | |
Outcome (Dependent variable - What you are measuring) | Conceptually: Operationally: |
Outcome Contrast (“Null hypothesis”) | Conceptually: Operationally: |
Population Context (Who, when, where) | Conceptually: Operationally: |
Types of Study Designs
Cheat Sheet
Study Design | Meta-Analysis, Systematic Review, Randomized Controlled Trial, Cohort Study, Case-control Study, Cross-sectional study,Case Reports and Series |
Exposure | “Cause” of what you are studying - medication, intervention, exposure etc. |
Exposure Contrast | Compared to what alternative - placebo, unexposed, alternate med/dose, etc. |
Etiologic Period | During what time period does the exposure matter - from birth to 2 years, during pregnancy, etc. |
Causal Direction | Effect - improves, worsens, increases, decreases, etc. |
Outcome | What you are measuring – cancer, happiness, IQ score, etc. |
Outcome Contrast | Absence of outcome – no cancer dx, etc |
Population Context | Who, when, where - residents in Worcester, MA, etc. |
Example of Journal Club Presentation
Background and Research Question
Background: Asthma is a common chronic condition among pediatric patients and is a common cause for presentation to the ED. Short-acting beta(2)-agonists are used to treat asthma symptoms. There are multiple modes of delivery for the medication.
Research Question: Is breath-enhanced nebulizer effective for treating asthma in pediatrics patients?
Cheat Sheet
Study Design | Meta-Analysis, Systematic Review, Randomized Controlled Trial, Cohort Study, Case-control Study, Cross-sectional study,Case Reports and Series |
Exposure | “Cause” of what you are studying - medication, intervention, exposure etc. |
Exposure Contrast | Compared to what alternative - placebo, unexposed, alternate med/dose, etc. |
Etiologic Period | During what time period does the exposure matter - from birth to 2 years, during pregnancy, etc. |
Causal Direction | Effect - improves, worsens, increases, decreases, etc. |
Outcome | What you are measuring – cancer, happiness, IQ score, etc. |
Outcome Contrast | Absence of outcome – no cancer dx, etc |
Population Context | Who, when, where - residents in Worcester, MA, etc. |
Abstract
Exposure
Etiologic Period
Causal Direction
Outcome
Context
Identify components of the causal hypothesis
Study Design (Type of study) | Randomized control trial |
Exposure (Independent variable - the “cause” of what you are studying) | Conceptually: breath-enhanced nebulizer treatment Operationally: 5 mg albuterol delivered via breath-enhanced system |
Exposure Contrast (Reference group - compared to what) | Conceptually: conventional jet delivery nebulizer treatment Operationally: 5 mg albuterol delivered via jet-delivery system |
Etiologic Period (Time period when exposure matters) | Conceptually: during acute asthma exacerbation Operationally: initial FEV1 <70% of predicted |
Causal Direction (Effect) | increases |
Outcome (Dependent variable - What you are measuring) | Conceptually: change in respiratory function Operationally: change in FEV1 (missing time frame! – how long after neb?!) |
Outcome Contrast (“Null hypothesis”) | Conceptually: no change in respiratory function Operationally: no change in FEV1 (missing time frame! – how long after neb?!) |
Population Context (Who, when, where) | Conceptually: children with acute asthma exacerbation in the ED Operationally: children 8-16 yo with moderate to severe acute asthma who presented to an urban ED during 20-month period from October 2015 to May 2017 |
Causal Hypothesis
Exposure → Outcome, in Context
Breath-enhanced delivery of albuterol compared to conventional jet delivery administered during acute asthma exacerbation causes a greater increase in FEV1 among pediatric patients 6-18 years old with a history of moderate to severe asthma while in the Emergency Department
Results
Clinical Implications
Next Steps